CTCAE RápidoAdverse event grades · CTCAE v6.0
Código Onco

Growth hormone abnormal

Investigations
  1. G1Asymptomatic; clinical or diagnostic observations only; intervention not indicated
  2. G2Symptomatic; medical intervention indicated; limiting instrumental ADL or mild/moderate impact on age-appropriate normal daily activity (pediatric)
  3. G3Not applicable
  4. G4Not applicable
  5. G5Not applicable
Definition and note

DefinitionA finding based on laboratory test results that indicate abnormal levels of growth hormone (GH) in a biological specimen.

MedDRA code (LLT): 10018748 · CTCAE v6.0 (NCI), original English text.

Other events in Investigations

Activated partial thromboplastin time prolongedAlanine aminotransferase increasedAlkaline phosphatase increasedAspartate aminotransferase increasedBlood antidiuretic hormone abnormalBlood bicarbonate decreasedBlood bilirubin increasedBlood corticotrophin decreasedBlood gonadotrophin abnormalBlood lactate dehydrogenase increasedBlood prolactin abnormalCarbon monoxide diffusing capacity decreasedCD4 lymphocytes decreasedCholesterol highCreatinine clearance decreasedCreatinine increasedElectrocardiogram QT corrected interval prolongedFibrinogen decreasedForced expiratory volume decreasedGGT increasedHaptoglobin decreasedHDL decreasedHemoglobin increasedINR increased

Search another event

From the same authorCódigo OncoCódigo Onco (in Portuguese): Brazilian public health system (SUS) codes for systemic cancer treatment.